Suppr超能文献

同源重组作为 DNA 复制过程中基本的基因组监测机制。

Homologous Recombination as a Fundamental Genome Surveillance Mechanism during DNA Replication.

机构信息

Novo Nordisk Foundation Center for Protein Research, Protein Signaling Program, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3b, DK-2200 Copenhagen, Denmark.

Functional Genomics and Metabolism Research Unit, Department of Biochemistry and Molecular Biology, University of Southern Denmark, Campusvej 55, DK-5230 Odense, Denmark.

出版信息

Genes (Basel). 2021 Dec 9;12(12):1960. doi: 10.3390/genes12121960.

Abstract

Accurate and complete genome replication is a fundamental cellular process for the proper transfer of genetic material to cell progenies, normal cell growth, and genome stability. However, a plethora of extrinsic and intrinsic factors challenge individual DNA replication forks and cause replication stress (RS), a hallmark of cancer. When challenged by RS, cells deploy an extensive range of mechanisms to safeguard replicating genomes and limit the burden of DNA damage. Prominent among those is homologous recombination (HR). Although fundamental to cell division, evidence suggests that cancer cells exploit and manipulate these RS responses to fuel their evolution and gain resistance to therapeutic interventions. In this review, we focused on recent insights into HR-mediated protection of stress-induced DNA replication intermediates, particularly the repair and protection of daughter strand gaps (DSGs) that arise from discontinuous replication across a damaged DNA template. Besides mechanistic underpinnings of this process, which markedly differ depending on the extent and duration of RS, we highlight the pathophysiological scenarios where DSG repair is naturally silenced. Finally, we discuss how such pathophysiological events fuel rampant mutagenesis, promoting cancer evolution, but also manifest in adaptative responses that can be targeted for cancer therapy.

摘要

准确而完整的基因组复制是细胞将遗传物质正确传递给细胞后代、正常细胞生长和基因组稳定的基本过程。然而,大量的外在和内在因素挑战着单个 DNA 复制叉,并导致复制应激(RS),这是癌症的一个标志。当受到 RS 的挑战时,细胞会利用广泛的机制来保护复制的基因组并限制 DNA 损伤的负担。其中突出的是同源重组(HR)。尽管对细胞分裂至关重要,但有证据表明,癌细胞利用和操纵这些 RS 反应来推动其进化并获得对治疗干预的抵抗。在这篇综述中,我们重点介绍了最近对 HR 介导的应激诱导 DNA 复制中间体保护的深入了解,特别是修复和保护源自受损 DNA 模板上不连续复制产生的子链缺口(DSG)。除了根据 RS 的程度和持续时间而明显不同的该过程的机制基础外,我们还强调了 DSG 修复自然沉默的病理生理情况。最后,我们讨论了这些病理生理事件如何引发猖獗的突变,促进癌症进化,但也表现出适应性反应,这些反应可以作为癌症治疗的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5a3/8701046/dc0f964771cc/genes-12-01960-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验